Diagonal Bio AB (publ) operates as a biotechnology company in Sweden. It is involved in developing the Panviral platform for detecting and diagnosing small sections of pathogen genomes, such as viruses, bacteria, and fungi. The company was incorporated in 2020 and is headquartered in Lund, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $0.001410589214869961 | N/A |
Market Cap | $56.39K | N/A |
Shares Outstanding | 39.98M | N/A |
Employees | 4.00 | N/A |